Evidence map›Paper›PMID 40735666›Full record

ArticleAsian biomedicine : research, reviews and news2025

Oculocutaneous albinism in a patient with an

Mostafa Neissi, Sahar Kareem Al-Mozani, Ayoob Radhi Al-Zaalan, Samaneh Sanavi Shiri, Motahareh Sheikh-Hosseini, Adnan Issa Al-Badran, Elaheh Nekouei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian biomedicine : research, reviews and news, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mostafa NeissiDepartment of Genetics, Khuzestan Science and Research Branch, Islamic Azad University, Ahvaz 61349-37333, Iran.
Sahar Kareem Al-MozaniDepartment of Biology, University of Misan, Misan 62001, Iraq.
Ayoob Radhi Al-ZaalanDepartment of Medical Lab Technology, College of Health and Medical Technology, Southern Technical University, Basrah 61006, Iraq.
Samaneh Sanavi ShiriAmiralmomenin Hospital, Gerash 74417-57897, Iran.
Motahareh Sheikh-HosseiniNoor-Gene Genetic Laboratory, Ahvaz, Iran.
Adnan Issa Al-BadranDepartment of Biology, College of Science, University of Basrah, Basrah 61004, Iraq.
Elaheh NekoueiDepartment of Biomedical and Clinical Science, Linköping University, University Hospital, Campus US, Linköping SE-581 83, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Albinism is a rare genetic condition characterized by hypopigmentation of the skin, hair, and eyes, as well as visual impairments. Oculocutaneous albinism type 2 ( Case presentation: A 27-year-old male from a consanguineous Iranian family presented with features of oculocutaneous albinism, including white hair, blue eyes, strabismus, sun-sensitive skin, reduced visual acuity, and significant photophobia, resulting in functional limitations in bright environments. Genetic analysis identified a novel homozygous missense variant in the Conclusion: The identified

Indexed as

anexome-sequencinggenetic diagnosisOCA2 geneoculocutaneous albinismvariant

Identifiers

PMID40735666
PMCPMC12303592

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.